Inflammatory Pathways in CVD and Diabetes: Broad-Spectrum Versus Selective Targeting.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.04.093
Abstract: Targeting inflammation is increasingly recognized as a novel therapeutic option in the management of type 2 diabetes and prevention of recurrent cardiovascular disease (CVD). In CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study), canakinumab had similar magnitude… read more here.
Keywords: pathways cvd; inflammatory pathways; broad spectrum; cvd diabetes ... See more keywords